Polyneuropathy in cerebrotendinous xanthomatosis and response to treatment with chenodeoxycholic acid

Journal of Neurology

Volumn 260, Issue 1, 2013, Pages 268-274

  Ginanneschi, F ^a   Mignarri, A ^a   Mondelli, M ^b   Gallus, G N ^a   Del Puppo, M ^c   Giorgi, S ^d   Federico, A ^a   Rossi, A ^a   Dotti, M T ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b ASL 7   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Cerebrotendinous xanthomatosis; Neuropathy; Neurophysiology

Indexed keywords

CHENODEOXYCHOLIC ACID; CHOLESTANETRIOL 26 MONOOXYGENASE; MYELIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CEREBROTENDINOUS XANTHOMATOSIS; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HUMAN; LABORATORY TEST; MALE; NERVE CONDUCTION; NERVE FIBER; POLYNEUROPATHY; PRIORITY JOURNAL; TREATMENT RESPONSE;

ACTION POTENTIALS; ADOLESCENT; ADULT; AGED; CHENODEOXYCHOLIC ACID; CHOLESTANETRIOL 26-MONOOXYGENASE; CHOLESTANOL; ELECTROMYOGRAPHY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MUTATION; NEURAL CONDUCTION; NEUROLOGIC EXAMINATION; NEUROPROTECTIVE AGENTS; POLYNEUROPATHIES; STATISTICS, NONPARAMETRIC; XANTHOMATOSIS, CEREBROTENDINOUS; YOUNG ADULT;

EID: 84872362010     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6630-3     Document Type: Article

References (19)

1. Federico A, Dotti MT (1996) Cerebrotendinous xanthomatosis. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology. Elsevier, Amsterdam, pp 599-613
2. Kuritzky A, Berginer VM, Korczyn AD (1979) Peripheral neuropathy in cerebrotendinous xanthomatosis. Neurology 29:880-881
3. Ohnishi A, Yamashita Y, Goto I, Kuroiwa Y, Murakami S, Ikeda M (1979) De- and remyelination and onion bulb in cerebrotendinous xanthomatosis. Acta Neuropathol (Berl) 45:43-45
4. Pop PH, Joosten E, van Spreeken A, Gabreëls-Festen A, Jaspar H, ter Laak H, Vos A (1984) Neuroaxonal pathology of central and peripheral nervous systems in cerebrotendinous xanthomatosis (CTX). Acta Neuropathol 64:259-264. doi: 10.1007/BF00688117
5. Argov Z, Soffer D, Eisenberg S, Fujiyama J, Osame M (1986) Chronic demyelinating peripheral neuropathy in cerebrotendinous xanthomatosis. Ann Neurol 20:89-91. doi: 10.1002/ana.410200115
6. Donaghy M, King RH, McKeran RO, Schwartz MS, Thomas PK (1990) Cerebrotendinous xanthomatosis: clinical, electrophysiological and nerve biopsy findings, and response to treatment with chenodeoxycholic acid. J Neurol 237:216-219. doi: 10.1007/BF00314598
7. Tokimura Y, Kuriyama M, Arimura K, Fujiyama J, Osame M (1992) Electrophysiological studies in cerebrotendinous xanthomatosis. J Neurol Neurosurg Psychiatry 55:52-55. doi: 10.1136/jnnp.55.1.52
8. Mondelli M, Rossi A, Scarpini C, Dotti MT, Federico A (1992) Evoked potentials in cerebrotendinous xanthomatosis and effect induced by chenodeoxycholic acid. Arch Neurol 49:469-475
9. Wang Z, Yuan Y, Zhang W, Zhang Y, Feng L (2007) Cerebrotendinous xanthomatosis with a compound heterozygote mutation and severe polyneuropathy. Neuropathology 27:62-66. doi: 10.1111/j.1440-1789.2006.00739.x
10. Verrips A, van Engelen BG, ter Laak H, Gabreëls-Festen A, Janssen A, Zwarts M, Wevers RA, Gabreëls FJ (2000) Cerebrotendinous xanthomatosis. Controversies about nerve and muscle: observations in ten patients. Neuromuscul Disord 10:407-414
11. Chen SF, Tsai NW, Chang CC, Lu CH, Huang CR, Chuang YC, Chang WN (2011) Neuromuscular abnormality and autonomic dysfunction in patients with cerebrotendinous xanthomatosis. BMC Neurol 11:63. doi: 10.1186/1471-2377-11-63
12. Pilo B, de Blas G, Sobrido MJ, Navarro C, Grandas F, Barrero FJ, Moya MA, Jimenez-Escrig A (2011) Neurophysiological study in cerebrotendinous xanthomatosis. Muscle Nerve 43:531-536. doi: 10.1002/mus.21905
13. Bromberg MB (2011) Review of the evolution of electrodiagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 43:780-794. doi: 10.1002/mus.22038
14. De Stefano N, Dotti MT, Mortilla M, Federico A (2001) Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis. Brain 124:121-131. doi: 10.1093/brain/124.1.121
15. Guerrera S, Stromillo ML, Mignarri A, Battaglini M, Marino S, Di Perri C, Federico A, Dotti MT, De Stefano N (2010) Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis. J Neurol Neurosurg Psychiatry 81:1189-1193. doi: 10.1136/jnnp.2009.203364
16. Restuccia D, Di Lazzaro V, Servidei S, Colosimo C, Tonali P (1992) Somatosensory and motor evoked potentials in the assessment of cerebrotendinous xanthomatosis before and after treatment with chenodeoxycholic acid: a preliminary study. J Neurol Sci 112:139-146
17. Mondelli M, Sicurelli F, Scarpini C, Dotti MT, Federico A (2001) Cerebrotendinous xanthomatosis: 11-year treatment with chenodeoxycholic acid in five patients. An electrophysiological study. J Neurol Sci 190:29-33. doi: 10.1016/S0022-510X(01)00563-9
18. Mignarri A, Rossi S, Ballerini M, lus GN, Del Puppo M, Galluzzi P, Federico A, Dotti MT (2011) Clinical relevance and neurophysiological correlates of spasticity in cerebrotendinous xanthomatosis. J Neurol 258:783-790. doi: 10.1007/s00415-010-5829-4
19. van Heijst AF, Verrips A, Wevers RA, Cruysberg JR, Renier WO, Tolboom JJ (1998) Treatment and follow-up of children with cerebrotendinous xanthomatosis. Eur J Pediatr 157:313-316. doi: 10.1007/s004310050818